
Yaws, caused by Treponema pallidum ssp. pertenue, is endemic in parts of West Africa, Southeast Asia and the Pacific. The WHO has launched a campaign based on mass treatment with azithromycin, to eradicate yaws by 2020.We reviewed published data, surveillance data and data presented at yaws eradication meetings.Azithromycin is now the preferred agent for treating yaws. Point-of-care tests have demonstrated their value in yaws.There is limited data from 76 countries, which previously reported yaws. Different doses of azithromycin are used in community mass treatment for yaws and trachoma.Yaws eradication appears an achievable goal. The programme will require considerable support from partners across health and development sectors.Studies to complete baseline mapping, integrate diagnostic tests into surveillance and assess the impact of community mass treatment with azithromycin are ongoing.
Cost-Benefit Analysis, Yaws, Humans, Articles, Treponema pallidum, Azithromycin, Disease Eradication, Program Development, Sentinel Surveillance, Anti-Bacterial Agents
Cost-Benefit Analysis, Yaws, Humans, Articles, Treponema pallidum, Azithromycin, Disease Eradication, Program Development, Sentinel Surveillance, Anti-Bacterial Agents
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 39 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
